A randomised study of protracted venous infusion of 5-fluorouracil (5-FU) with or without bolus mitomycin C (MMC) in patients with carcinoma of unknown primary-Reference-Cited by-同舟云学术

A randomised study of protracted venous infusion of 5-fluorouracil (5-FU) with or without bolus mitomycin C (MMC) in patients with carcinoma of unknown primary

Published:2003-05 Issue:8 Volume:39 Page:1121-1128
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Assersohn L,Norman A.R,Cunningham D,Iveson T,Seymour M,Hickish T,Massey A,Prior Y,Hill M.E

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. Management of patients with cancer of unknown primary site;Hainsworth;Oncology,2000

2. Unknown primary carcinoma;Abbruzzese;J. Clin. Oncol.,1994

3. A phase I/II study of leucovorin, carboplatin and 5-fluorouracil (LCF) in patients with carcinoma of unknown primary site or advanced oesophagogastric/pancreatic adenocarcinomas;Rigg;Br. J. Cancer,1997

4. Phase II study of epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) for carcinoma of unknown primary site;Parnis;Ann. Oncol.,2000

5. Carcinoma of an unknown primary site;Saghatchian;Ann. Oncol.,2001

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Redefining cancer of unknown primary: Is precision medicine really shifting the paradigm?;Cancer Treatment Reviews;2021-06

2. Treatment of Disseminated CUP;Cancer of Unknown Primary;2016

3. E28 Literaturhinweise und Internetadressen;Facharzt Hämatologie Onkologie;2015

4. CUP – Internistische Therapie bei ungünstigem Risikoprofil;Der Onkologe;2012-12-19

5. Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis;British Journal of Cancer;2012-11-22